Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
14 pending office actions • 3 clients • 14 examiners • 10 art units • 0 of 14 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
POLSINELLI PC - UTSW handles 266 career applications in the Biotechnology & Pharmaceuticals technology area. The resolved allowance rate_pct for this client is 63.33. There are currently 11 pending office actions in the prosecution pipeline.
The firm achieves an average of 1.79 office actions per allowance for UTSW. This metric describes the prosecution process for the 266 career applications. The 63.33 resolved allowance rate_pct and 11 pending office actions provide a snapshot of the activity levels for this client in the Biotechnology & Pharmaceuticals field.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (21%) |
| §103 only | 2 (14%) |
| §102 only | 1 (7%) |
| §112 only | 2 (14%) |
| Multi-statute (no §101) | 6 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEMIEUX, IAN L | 1 | 86.8% | +9.1% |
| KELLEY, CHRISTOPHER S | 1 | 29.2% | +12.1% |
| BERRY, LAYLA D | 1 | 66.0% | +9.0% |
| COUGHLIN, MATTHEW P | 1 | 71.3% | +12.4% |
| TSUI, YUNG-SHENG M | 1 | 66.4% | +6.6% |
| GODDARD, LAURA B | 1 | 50.9% | +13.5% |
| KINSEY WHITE, NICOLE ERIN | 1 | 58.1% | +16.4% |
| BAILEY, STEVEN WILLIAM | 1 | 31.6% | +15.2% |
| CHANDRA, GYAN | 1 | 71.3% | +27.5% |
| KONOPKA, CATHERINE ANNE | 1 | 58.1% | +65.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18265226 | COMPOSITIONS TARGETING WDR37 AND METHODS OF USE THEREOF | KONOPKA, CATHERINE ANNE | 3d overdue |
| 18271173 | ENGINEERED STABLE ACE2 PROTEIN VARIANTS AS ANTIVIRAL NEBULIZED THERAPEUTICS | CHANDRA, GYAN | 70d |
| 18784134 | METHODS FOR HIGH-PERFORMANCE ELECTRON MICROSCOPY | LEMIEUX, IAN L | — |
| 18833074 | DORSAL MEDULLA SURFACE TEXTURE AS AN IMAGING METRIC TO DISTINGUISH BETWEEN NEUROLOGICAL DISORDERS SYSTEMS AND METHODS | KELLEY, CHRISTOPHER S | — |
| 18730565 | COMPOSITIONS AND METHODS OF REGENERATING HEART TISSUES WITH AMINOGLYCOSIDES | BERRY, LAYLA D | — |
| 18686802 | BETA ADRENERGIC RECEPTOR COMPOSITIONS AND METHODS OF USE THEREOF | COUGHLIN, MATTHEW P | — |
| 18409612 | METHODS AND COMPOSITIONS FOR MUTAGENESIS SCREENING IN MAMMALIAN CELLS | TSUI, YUNG-SHENG M | — |
| 18561044 | POLY-ADP RIBOSE (PAR) TRACKER OPTIMIZED SPLIT-PROTEIN REASSEMBLY PAR DETECTION REAGENTS | GODDARD, LAURA B | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18265226 | COMPOSITIONS TARGETING WDR37 AND METHODS OF USE THEREOF | KONOPKA, CATHERINE ANNE | 3d overdue |
| 18271173 | ENGINEERED STABLE ACE2 PROTEIN VARIANTS AS ANTIVIRAL NEBULIZED THERAPEUTICS | CHANDRA, GYAN | 70d |
| 18833074 | DORSAL MEDULLA SURFACE TEXTURE AS AN IMAGING METRIC TO DISTINGUISH BETWEEN NEUROLOGICAL DISORDERS SYSTEMS AND METHODS | KELLEY, CHRISTOPHER S | — |
| 18686802 | BETA ADRENERGIC RECEPTOR COMPOSITIONS AND METHODS OF USE THEREOF | COUGHLIN, MATTHEW P | — |
| 18561044 | POLY-ADP RIBOSE (PAR) TRACKER OPTIMIZED SPLIT-PROTEIN REASSEMBLY PAR DETECTION REAGENTS | GODDARD, LAURA B | — |
| 18286855 | DETECTION OF SARS-COV-2 VARIANT | KINSEY WHITE, NICOLE ERIN | — |
| 18469022 | COMPUTATIONAL SYSTEM AND METHOD FOR DIAGNOSIS, PROGNOSIS, AND THERAPEUTICS OF CANCER PATIENTS USING SPATIAL-TEMPORAL TISSUE ARCHITECTURAL PROPERTIES | BAILEY, STEVEN WILLIAM | — |
| Client (Assignee) | Pending OAs |
|---|---|
| University of Texas | 12 |
| University of Alabama at Birmingham | 1 |
| University of Nebraska | 1 |
| Art Unit | Apps |
|---|---|
| 2669 | 1 |
| 1626 | 1 |
| 1618 | 1 |
| 1672 | 1 |
| 1674 | 1 |
| 1635 | 1 |
| 3783 | 1 |
| 1798 | 1 |
| 1632 | 1 |
| 3715 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18784134 | METHODS FOR HIGH-PERFORMANCE ELECTRON MICROSCOPY | The Board Of Regents Of The University Of Texas System | LEMIEUX, IAN L | 2669 | §101§112 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18833074 | DORSAL MEDULLA SURFACE TEXTURE AS AN IMAGING METRIC TO DISTINGUISH BETWEEN NEUROLOGICAL DISORDERS SYSTEMS AND METHODS | The Board Of Regents Of The University Of Texas System | KELLEY, CHRISTOPHER S | §103 | Non-Final OA | — | Pending | Jul 25, 2024 | |
| 18730565 | COMPOSITIONS AND METHODS OF REGENERATING HEART TISSUES WITH AMINOGLYCOSIDES | The UAB Research Foundation | BERRY, LAYLA D | §102§103 | Non-Final OA | — | Pending | Jul 19, 2024 | |
| 18686802 | BETA ADRENERGIC RECEPTOR COMPOSITIONS AND METHODS OF USE THEREOF | The Board Of Regents Of The University Of Texas System | COUGHLIN, MATTHEW P | 1626 | §103§112 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18409612 | METHODS AND COMPOSITIONS FOR MUTAGENESIS SCREENING IN MAMMALIAN CELLS | The Board Of Regents Of The University Of Texas System | TSUI, YUNG-SHENG M | §102§103 | Non-Final OA | — | Pending | Jan 10, 2024 | |
| 18561044 | POLY-ADP RIBOSE (PAR) TRACKER OPTIMIZED SPLIT-PROTEIN REASSEMBLY PAR DETECTION REAGENTS | The Board Of Regents Of The University Of Texas System | GODDARD, LAURA B | 1618 | §102§103§112 | Non-Final OA | — | Pending | Nov 15, 2023 |
| 18286855 | DETECTION OF SARS-COV-2 VARIANT | The Board Of Regents Of The University Of Texas System | KINSEY WHITE, NICOLE ERIN | 1672 | §112 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18469022 | COMPUTATIONAL SYSTEM AND METHOD FOR DIAGNOSIS, PROGNOSIS, AND THERAPEUTICS OF CANCER PATIENTS USING SPATIAL-TEMPORAL TISSUE ARCHITECTURAL PROPERTIES | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | BAILEY, STEVEN WILLIAM | §101§102§103 | Non-Final OA | — | Pending | Sep 18, 2023 | |
| 18271173 | ENGINEERED STABLE ACE2 PROTEIN VARIANTS AS ANTIVIRAL NEBULIZED THERAPEUTICS | The Board Of Regents Of The University Of Texas System | CHANDRA, GYAN | 1674 | §102§112 | Final Rejection | 70d | Pending | Jul 06, 2023 |
| 18265226 | COMPOSITIONS TARGETING WDR37 AND METHODS OF USE THEREOF | The Board Of Regents Of The University Of Texas System | KONOPKA, CATHERINE ANNE | 1635 | §102§103§112 | Non-Final OA | 3d overdue | Pending | Jun 02, 2023 |
| 18196262 | TUBE SECUREMENT DEVICE AND METHODS | The Board Of Regents Of The University Of Texas System | RITCHIE, HADEN MATTHEW | 3783 | §102 | Non-Final OA | — | Pending | May 11, 2023 |
| 18249864 | HIGH THROUGHPUT CELL MIGRATION ASSAY PLATES AND METHODS OF FABRICATION | The Board Of Regents Of The University Of Texas System | HANDY, DWAYNE K | 1798 | §103 | Final Rejection | — | Pending | Apr 20, 2023 |
| 18249661 | METHODS FOR GENERATING FORMATIVE PLURIPOTENT STEM CELLS COMPETENT FOR DIRECT PRIMORDIAL GERM CELL INDUCTION | The Board Of Regents Of The University Of Texas System | MONTANARI, DAVID A | 1632 | §112 | Final Rejection | 8d overdue | Pending | Apr 19, 2023 |
| 17889946 | SYSTEMS, METHODS, AND APPARATUSES TO PROVIDE CHEST TUBE INSERTION FEEDBACK | The Board Of Regents Of The University Of Texas System | ALSOMAIRY, SELWA ABDO | 3715 | §101§112 | Non-Final OA | — | Pending | Aug 17, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial